Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

irinotecan

  • You have access
    Phase II Study of Carboplatin and Weekly Irinotecan Combination Chemotherapy in Recurrent Ovarian Cancer: A Kansai Clinical Oncology Group Study (KCOG0330)
    HIROSHI TSUBAMOTO, RYUJI KAWAGUCHI, KIMIHIKO ITO, TAKAYA SHIOZAKI, SATOSHI TAKEUCHI, YOSHIO ITANI, ATSUSHI ARAKAWA, TSUTOMU TABATA and SHINJI TOYODA
    Anticancer Research March 2013, 33 (3) 1073-1079;
  • You have access
    Alternating Chemotherapy with Amrubicin Plus Cisplatin and Weekly Administration of Irinotecan Plus Cisplatin for Extensive-stage Small Cell Lung Cancer
    RINTARO NORO, AKINOBU YOSHIMURA, KAZUO YAMAMOTO, AKIHIKO MIYANAGA, HIDEAKI MIZUTANI, YUJI MINEGISHI, MASAHIRO SEIKE, KAORU KUBOTA, SEIJI KOSAIHIRA, MITSUNORI HINO, MASAHIRO ANDO, KOICHIRO NOMURA, TETSUYA OKANO, KUNIHIKO KOBAYASHI, KAZUTSUGU UEMATSU, AKIHIKO GEMMA and The East Japan Chesters Group
    Anticancer Research March 2013, 33 (3) 1117-1123;
  • You have access
    Combined Colonic Cancer Treatment with Vitamin D Analogs and Irinotecan or Oxaliplatin
    MAGDALENA MILCZAREK, SARA ROSIŃSKA, MATEUSZ PSURSKI, MAGDALENA MACIEJEWSKA, ANDRZEJ KUTNER and JOANNA WIETRZYK
    Anticancer Research February 2013, 33 (2) 433-444;
  • You have access
    Hepatic Arterial Infusion of Irinotecan, 5-Fluorouracil and Leucovorin in Patients with Liver Metastases from Colorectal Carcinoma
    BOHUSLAV MELICHAR, ZBYNĚK VOBOŘIL, ANTONÍN KRAJINA, EVA MALÍŘOVÁ, PAVEL WEINER, MARKÉTA NOVÁ, ALEŠ RYŠKA and JOSEF DVOŘÁK
    Anticancer Research December 2012, 32 (12) 5487-5493;
  • You have access
    Analysis of Type of Cell Death Induced by Topoisomerase Inhibitor SN-38 in Human Oral Squamous Cell Carcinoma Cell Lines
    NOZOMI TAMURA, KUMI HIRANO, KAORI KISHINO, KEN HASHIMOTO, OSAMU AMANO, JUN SHIMADA and HIROSHI SAKAGAMI
    Anticancer Research November 2012, 32 (11) 4823-4832;
  • You have access
    Combination Chemotherapy of Alternating Etoposide and Carboplatin with Weekly Administration of Irinotecan and Cisplatin in Extensive-stage Small-cell Lung Cancer
    AKINOBU YOSHIMURA, RINTARO NORO, AKIHIKO MIYANAGA, HIDEAKI MIZUTANI, SEIJI KOSAIHIRA, YUJI MINEGISHI, MASAHIRO SEIKE, MITSUNORI HINO, MASAHIRO ANDO, KOICHIRO NOMURA, TETSUYA OKANO, KUNIHIKO KOBAYASHI, AKIHIKO GEMMA and THE EAST JAPAN CHESTERS GROUP
    Anticancer Research October 2012, 32 (10) 4473-4478;

Pages

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire